On 6 March 2013, MicroVention announced that its new manufacturing facility in San Jose, Costa Rica has opened. The company also held a Grand Opening Ceremony to commemorate this venture for MicroVention. The new plant represents MicroVention’s first manufacturing facility outside the USA and the first neurovascular manufacturing facility in Costa Rica, which is located at the Coyol Free Zone in the Alajuela region of Costa Rica.
The Plant opening ceremony was attended by numerous dignitaries and executives from the business district including the vice president of Costa Rica, Luis Lieberman Ginsburg. Other executives who attended from MicroVention’s parent company included Yutaro Shintaku, president and representative director; Shinjiro Sato, senior executive officer, group president, Cardiac and Vascular Business Group (both of Terumo Corporation located in Tokyo, Japan) and Hideo Arase, president and CEO of Terumo Americas Holding. Also in attendance was the Costa Rican investment promotion agency (CINDE) which, according to a company release, supported MicroVention in establishing its plant in Costa Rica.
“MicroVention will be the first company specialising in the neurovascular segment, and we are excited to welcome MicroVention to the Alajuela region,” commented Gabriela Llobet, CINDE´s director general.
“We are very excited about the initiation of our first manufacturing facility in Costa Rica and commemorating the opening with many of our new partners celebrating with us. Our intent was to create a world-class facility extension of our corporate manufacturing plant in Tustin, CA, USA, and we have achieved that goal today,” said Richard Cappetta, president and chief executive officer of MicroVention.
In attendance besides the company’s president and CEO were several other members of the MicroVention executive staff including William R Hughes, chief operating officer and treasurer; Cherie Henket, vice president, Human Resources; Matt Fitz Sr vice president, Research and Development and Operations; Uichi Okina, vice president, Strategic Planning, Business Development; and Charlie Noel, Vice President, Operations.
According to the company, approximately 12,000 people currently work in the Life Sciences Sector in Costa Rica. MicroVention will be the first company specialising in the neurovascular segment in Costa Rica.